Meropenem Stada

Meropenem, the active ingredient in Meropenem Stada, is a carbapenem antibiotic presented as an injection solution for intravenous use. It treats severe bacterial infections such as complicated intra‑abdominal infections, complicated urinary tract infections, hospital‑acquired pneumonia, severe sepsis, septic shock and meningitis caused by susceptible organisms.

GNH USA supplies Meropenem Stada as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Meropenem is used to treat infections caused by susceptible Gram‑negative and Gram‑positive bacteria across several clinical categories. - Complicated intra‑abdominal infections: provides rapid bactericidal activity to help resolve the infection. - Complicated urinary tract infections: eliminates the causative pathogens, facilitating clinical cure. - Hospital‑acquired pneumonia: achieves bacterial clearance in the lungs, improving respiratory function. - Severe sepsis and septic shock: offers broad‑spectrum coverage to control systemic infection. - Meningitis caused by susceptible organisms: penetrates the cerebrospinal fluid to eradicate the infecting bacteria.

Adverse reactions to Meropenem may vary in frequency and severity.

Common Side Effects: - Nausea: mild to moderate gastrointestinal discomfort. - Diarrhea: loose stools, sometimes watery. - Headache: transient cranial pain. - Injection site reactions: erythema or pain at the infusion site.

Serious or Rare Side Effects: - Seizures: especially in patients with renal impairment or CNS disorders. - Clostridioides difficile colitis: severe diarrhea due to intestinal flora disruption. - Anaphylaxis: acute, potentially life‑threatening allergic reaction.

Before initiating Meropenem therapy, clinicians should consider several safety measures. - Renal function: adjust dose in patients with impaired kidney function. - History of seizures: use cautiously in individuals with pre‑existing seizure disorders. - Allergy assessment: avoid in patients with known hypersensitivity to carbapenems or β‑lactams. - Concurrent antibiotics: monitor for antagonistic effects when combined with bacteriostatic agents. - Pregnancy and lactation: weigh potential benefits against unknown risks. - Store at 2‑8°C: keep refrigerated, protect from light, do not freeze or shake.

Meropenem may interact with other medicines, affecting efficacy or safety.

Major Interactions (Avoid): - Valproic acid: concomitant use can reduce valproate levels, risking seizure breakthrough. - Probenecid: may increase meropenem plasma concentrations, raising toxicity risk.

Moderate Interactions (Monitor Closely): - Aminoglycosides: combined nephrotoxic potential requires renal function monitoring. - Loop diuretics: may enhance ototoxicity when used together. - Bacteriostatic antibiotics (e.g., chloramphenicol, tetracyclines): may antagonize the bactericidal action of meropenem.